Home › Funds › Two Sigma Investments › LIXT
Two Sigma Investments position in LIXT
LIXTE BIOTECHNOLOGY HLDGS IN
Latest position (Q4 2025)15.17K sh
Reported value held$59.63K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 16.95K | $13.00K | New |
| Q3 2022 | 21.27K | $12.00K | Add |
| Q4 2022 | 19.87K | $10.12K | Reduce |
| Q1 2023 | 24.90K | $20.60K | Add |
| Q4 2025 | 15.17K | $59.63K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LIXT
- Geode Capital Management 143.04K sh · $1.06M · Q2 2026
- BlackRock Inc 75.96K sh · $563.61K · Q2 2026
- Vanguard Group 74.94K sh · $294.53K · Q4 2025
- Wells Fargo & Co 5 sh · $37 · Q2 2026